Skip to search form
Skip to main content
Skip to account menu
Semantic Scholar
Semantic Scholar's Logo
Search 218,250,719 papers from all fields of science
Search
Sign In
Create Free Account
Sch 52365
Known as:
SCH52365
National Institutes of Health
Create Alert
Alert
Related topics
Related topics
2 relations
Temodar
Broader (1)
temozolomide
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
2004
2004
A phase II study of Temozolomide in advanced untreated pancreatic cancer
M. Moore
,
R. Feld
,
D. Hedley
,
A. Oza
,
L. Siu
Investigational new drugs
2004
Corpus ID: 10073619
Temozolomide (SCH 52365) is an imidazotetrazine derivative which exhibits broad spectrum activity against murine tumors and is…
Expand
1998
1998
Phase II study of Temodal in the treatment of patients with advanced nasopharyngeal carcinoma
A. Chan
,
T. Leung
,
+4 authors
P. Johnson
Cancer Chemotherapy and Pharmacology
1998
Corpus ID: 1534818
Purpose: A single-institution phase II trial of Temodal (temozolomide, SCH52365) in Chinese patients with advance nasopharyngeal…
Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our
Privacy Policy
(opens in a new tab)
,
Terms of Service
(opens in a new tab)
, and
Dataset License
(opens in a new tab)
ACCEPT & CONTINUE